Here is a selection of some of our current and recent studies on quitting smoking:
The GEMS will test a novel mHealth app for people who are not necessarily ready to stop smoking. Learn more here.
The Oral Health 4 Life study looked at the effects of integrating an oral health promotion program into standard care offered through state-funded tobacco quitlines. Results from this large, randomized, semi-pragmatic trial suggested that promoting oral health in conjunction with tobacco cessation may help smokers give up tobacco. The intervention did not increase use of professional dental care, it but did improve smokers’ daily oral hygiene (brushing and flossing).
My Mobile Advice Program (MyMAP) evaluated a new smart phone app developed by researchers at Kaiser Permanente Washington Health Research Institute, the University of California, and the University of Michigan. The program was designed to support smoking cessation and improve participants medication adherence.
Partnering to Achieve Tobacco-free Health (PATH) was a joint study between Kaiser Permanente Washington Health Research Institute and the Fred Hutchinson Cancer Research Center. This clinical trial compared compare how well different types of group-based counseling work to help people quit smoking.
What content and design features are important to include in online smoking cessation programs to make them more effective? That’s the question the Questions about Quitting (Q2) study addressed. Q2 was a collaboration between researchers at Kaiser Permanente Washington Health Research Institute and the University of Michigan. More than 1,800 Kaiser Permanente Washington members participated in this innovative study, which the National Cancer Institute funded.
The BEACON study looked at whether it is possible to offer people different treatment (stop-smoking medicine and counseling) based on their genes. Results from this pilot study showed that not only was it possible to do this, but the treatment was well accepted. This study was a collaboration between researchers at Kaiser Permanente Washington Health Research Institute and Stanford University.
The Step Up trial was a pilot project that evaluated the preliminary effectiveness of combining counseling for depression, physical activity, and quitting smoking into a single phone-delivered intervention. The results demonstrated the approach warrants further research in a larger randomized trial.
The COMPASS trial compared three different forms of behavioral counseling (phone counseling, Web-based counseling, and phone + web counseling) to determine which was more effective when combined with Chantix® (varenicline). Phone counseling appeared to do better during early treatment, but long-term stop smoking rates did not differ. All three programs were effective when combined with varenicline. The study also examined Chantix side effects and found they were generally mild to moderate for most smokers.
We often seek Kaiser Permanente Washington members and others to help us evaluate new treatment programs. To learn more about quit-smoking studies that are seeking volunteers, please contact Ella Thompson at 206-442-5211 or Ella.E.Thompson@kp.org.
Director of Research, Faculty, & Development; Senior Investigator
Kaiser Permanente Washington Health Research Institute
Tobacco remains a public health priority. Dr. Jennifer McClure discusses her new findings comparing 'acceptance and commitment therapy' to standard care.
Read about it in Healthy Findings.
Dr. Jennifer McClure applauds the American Cancer Society's recent strike against tobacco that burns. And she unpacks its evidence-based stance on e-cigarettes.
Read about it in Healthy Findings.